glp-1 and inflammation A Closer Look at the Dermatological Profile of Agonists GLP-1 Medication: Treatments for Chronic

doi: 10.1038/s41590-019-0433-y 12 HilfNKuttruff-CoquiSFrenzelKBukurVStevanovicSGouttefangeasCet al

Divided into three groups, participants received oral supplementation of GSH (250 mg/d), GSSG (250 mg/d), or a placebo for 12 weeks

Environmental endocrine disrupting chemical-DEHP exposure-provoked biotoxicity about microbiota-gut-mammary axis in lactating mice via multi-omics technologies

Using GSTP1-deficient MCF-7 cancer cells and siRNA interference targeting GSTP1 in HaCaT keratinocytes expressing either wild-type or mutant HPV-16 E7, we uncovered a pivotal role for GSTP1 in the pro-survival program elicited by its binding with HPV-16 E7

Bn nn ung nc khi tng lng cht x hoc b sung beta-glucan